Electronic Cigarette Use
53
8
8
41
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.9%
1 terminated out of 53 trials
97.6%
+11.1% vs benchmark
4%
2 trials in Phase 3/4
22%
9 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 41 completed trials
Clinical Trials (53)
Developing and Testing Health Warning Labels on the ENDS Device
Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems
Methadone-Maintained Smokers Switching to E-Cigarettes
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
Cessation of Smoking Trial in the Emergency Department
Development of UP2UTobacco for High School Youth
The Avenues Study: Dual Use Cessation
Effect of Cannabis on E-Cigarette Use Behavior
Effect of Menthol on ENDS Users' Addiction and Exposure
Assessing Electronic Cigarette Nicotine Flux
Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
The Impact of Oral Ethanol and Vaped Ethanol on the Evaluation of Impairment
Effects of E-cigarette Use on Health
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes
E-cigarettes for Harm Reduction in Adults With Asthma
Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures
Dual Use of ENDS and Combustible Cigarettes
CSD201203: A Study to Determine Subject Puffing Patterns of a Non-cylindrical, Closed, Electronic Nicotine Delivery System at Three Nicotine Concentrations in an Ambulatory Setting